Stay updated on Olaparib & Atezolizumab in BRCA+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Olaparib & Atezolizumab in BRCA+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Olaparib & Atezolizumab in BRCA+ Breast Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    UPMC Hillman Cancer Center was added as a Pittsburgh study site, and University of Pittsburgh Cancer Institute (UPCI) was removed from the listed locations.
    Difference
    0.1%
    Check dated 2026-08-06T16:39:51.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.3 to v3.6.4. This reflects a new revision release of the Study Details page, likely including minor fixes or tweaks to metadata or content.
    Difference
    0.0%
    Check dated 2026-07-23T09:47:10.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The page now displays revision v3.6.3, replacing the previous revision v3.6.1. This indicates a version update to the page, likely reflecting minor edits or corrections rather than substantive changes to study information.
    Difference
    0.0%
    Check dated 2026-07-02T02:24:04.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The page's Revision tag changed from v3.6.0 to v3.6.1, signaling a minor version update to the page metadata.
    Difference
    0.0%
    Check dated 2026-06-24T20:30:05.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    New help and navigation sections were added to improve reader access to study information, including How to Read a Study Record, Common Questions, and How to Join a Study. The page now shows an updated revision tag (Revision: v3.6.0) and standardizes the Intervention/Treatment label, replacing the previous Interventions / Treatment formatting and removing the older revision tag.
    Difference
    0.2%
    Check dated 2026-06-16T18:37:59.000Z thumbnail image
  9. Check
    73 days ago
    Change Detected
    Summary
    - Revision updated from v3.5.4 to v3.5.5, indicating a small metadata update to the page.
    Difference
    0.0%
    Check dated 2026-06-09T14:56:29.000Z thumbnail image

Stay in the know with updates to Olaparib & Atezolizumab in BRCA+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Olaparib & Atezolizumab in BRCA+ Breast Cancer Clinical Trial page.